P/E ratio for CONMED (CNMD)

P/E ratio history for CONMED from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Boston Scientific BSX	126	236.94%	🇺🇸 USA
Smith & Nephew SNN	22.9	-38.68%	🇬🇧 UK
Teleflex TFX	21.3	-42.99%	🇺🇸 USA
Medtronic MDT	33.8	-9.32%	🇮🇪 Ireland
Integra LifeSciences IART	21.6	-42.11%	🇺🇸 USA
Stryker Corporation SYK	57.3	53.73%	🇺🇸 USA
Johnson & Johnson JNJ	10.9	-70.90%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.